Delivery Order SPE2DB22D3501-SPE2DB25FXC20
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Isotretinoin 30 mg capsules (30-count units) with a ceiling value of $7,051.35. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Isotretinoin 30 mg capsules in quantities of 30, with a ceiling value of $2,347.10. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Isotretinoin 30 mg capsules (30-count) with a contract value of $2,590.48. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement practices. The pharmaceutical product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania, with an ultimate completion date of August 25, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Isotretinoin 30 mg capsules in quantities of 10, with a contract ceiling value of $1,688.16. This competitively awarded, non-set-aside delivery order carries a firm fixed price structure and is scheduled for ultimate completion by June 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at...
- The Department of Defense's Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Isotretinoin 30 mg capsules in quantities of 30 units, with a contract ceiling value of $17,955.69. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and was awarded without a set-aside designation, indicating it was awarded through open competition. The contract is executed from AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Isotretinoin 30 mg capsules (30-count units) with a ceiling value of $3,148.80. This firm fixed-price delivery order is not set-aside and represents performance work to be completed by the ultimate completion date of September 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $7,847.37 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Isotretinoin 30 mg capsules (30-count units). This is a firm fixed price, non-set-aside contract with a completion date of September 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $2,868.79 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with DLA. The work will be performed at the contractor's corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,107.60 for Isotretinoin 30 mg capsules (30-count units) on September 12, 2025, with a completion date of September 15, 2025. This is a firm fixed price, non-set-aside contract to be performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $2,522.91 delivery order to AmerisourceBergen Drug Corp for 30 capsules of Isotretinoin 30 mg on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical vendor for federal medical procurement, serving...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXC20Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Isotretinoin 30 mg capsules (30-count units) with a ceiling value of $2,395.99. This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by September 2, 2025. The performance location is identified as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and primary distribution hub. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor agreement enables the contractor to supply pharmaceutical products and medical supplies to support military healthcare programs globally, including medications, vaccines, and specialized medical commodities. AmerisourceBergen's consistent receipt of competitively awarded delivery orders across multiple therapeutic domains demonstrates its established capability as a critical pharmaceutical distributor for federal medical procurement, particularly for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 8/29/25 |